F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway
Introduction
Colorectal carcinoma (CRC) ranks the third most common malignant tumor in men and the second most common type of malignant tumor in women [1]. In 2012, approximately 694,000 CRC-related deaths were recorded [1]. In patients with stage I disease, 5-year relative survival is greater than 90%. However, survival is only slightly greater than 10% in stage IV CRC patients [2,3]. Despite efforts have been made to improve clinical treatment, the prognosis of colon cancer patients has shown no marked progress in recent years. Therefore, it is essential to explore the cancer biology underlying colon cancer.
The ubiquitin protein ligase complex SKP1-cullin-F-box is made up of Skp1, Cullin 1, and an F-box protein that interacts with many substrates for proteasome-dependent destruction [4]. Accumulated evidence suggests that this complex plays crucial roles in tumorigenesis via modulating cell proliferation, apoptosis, metastasis, and angiogenesis [5]. For example, recent studies have identified that FBXW7 is a haplo-insufficient tumor suppressor, which targets several proto-oncoproteins, including cyclin E, c-Myc, c-jun, and Mcl1, for degradation [[6], [7], [8]]. F-box and leucine-rich repeat protein 5 (FBXL5) is a member of the F-box protein family, which is characterized by an F-box motif consisting of 40 amino acids [[9], [10], [11]]. Until now, FBXL5 is reported to function as a tumor suppressor in gastric cancer [[12], [13], [14]] and cervical cancer [15]. However, the effects of FBXL5 in colon cancer and the underlying molecular mechanism have remained unclear.
Phosphatase and tensin homolog, deleted on chromosome 10 (PTEN), a major tumor suppressor, has been identified to play a vital role in colon carcinogenesis [16]. PTEN induces lipid phosphatase activity and regulates cell survival and apoptosis through repressing the oncogenic PI3K/AKT signaling [17,18]. Besides, PTEN, as a phosphatase for phosphoinositol lipids, also plays an important role in the regulation of tumor metastasis [19], including colon cancer [20,21]. In our preliminary study, we found that overexpression of FBXL5 induced excessive activation of the PI3K/AKT signaling pathway in colon cancer (Fig. 3A). However, the molecular mechanism of FBXL5 and PI3K/AKT in colon cancer progression remains unclear.
In view of the association of FBXL5 expression with PI3K/AKT signaling activation, the present study investigated the effects and underlying mechanism of FBXL5 and PI3K/AKT in colon cancer occurrence and development. Results demonstrated that FBXL5 expression was elevated in colon cancer, which improved cell growth and tumorigenesis and repressed cell apoptosis by modulating the PI3K/AKT signaling pathway in which the expression PTEN was decreased, whereas that of AKT, PI3K, and mammalian rapamycin (mTOR) was increased. These findings point to a new therapeutic strategy for colon cancer.
Section snippets
Patients and sample preparation
The study was approved by the Human Research Committee of Southwest Medical University and was performed in accordance with the Helsinki Declaration. The colon cancer samples and paired adjacent non-tumor tissues were obtained from patients with colon cancer. And all of the patients receipted a radical colectomy only without any form of chemotherapy or radiation.
Immunohistochemistry
Paraffin sections of colon tissues were sliced into sections that were 4 μm thick by a slicing machine. Then, staining protocol was
Increased expression of FBXL5 in colon cancer tissues and cell lines
To explore the effects of FBXL5 on the development of colon cancer, we firstly determined the expression pattern of FBXL5 in colon cancer tissues and cell lines. Results of the immunohistochemistry analysis of FBXL5 expression in 29 paired colon cancer tissues and adjacent tissues showed that the score of FBXL5 protein expression in colon cancer tissues was significantly higher than that in the adjacent tissues (Fig. 1A). Western blotting and RT-PCR analysis demonstrated that both the protein
Discussion
FBXL5−/− mice show an embryonic lethality phenotype, with growth defects readily apparent prior to day E9, despite normal placentation, cardiovascular, and gastrulation development [25]. Previous biochemical studies demonstrated that FBXL5 played a critical role in the maintenance of cellular iron homeostasis by targeting IRP1 and IRP2 for ubiquitination [26]. Research also showed that cells from FBXL5 knockout mice showed a tendency toward apoptosis due to unrestrained IRP activity, which is
Competing interests
The authors declare that they have no competing interests.
References (38)
- et al.
Colorectal cancer
Lancet
(2014) - et al.
HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism
J. Biol. Chem.
(2014) - et al.
F-box and leucine-rich repeat protein 5 (FBXL5): sensing intracellular iron and oxygen
J. Inorg. Biochem.
(2014) - et al.
F-box and leucine-rich repeat protein 5 (FBXL5) is required for maintenance of cellular and systemic iron homeostasis
J. Biol. Chem.
(2013) - et al.
PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer
Am. J. Pathol.
(2010) - et al.
Phosphatase and tensin homolog (PTEN) represses colon cancer progression through inhibiting paxillin transcription via PI3K/AKT/NF-kappaB pathway
J. Biol. Chem.
(2015) - et al.
The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo
Cell Metab.
(2011) - et al.
Structural and molecular characterization of iron-sensing hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5)
J. Biol. Chem.
(2012) - et al.
Clinical significance of tumor suppressor PTEN in colorectal carcinoma
Eur. J. Surg. Oncol.
(2011) - et al.
Global cancer statistics
CA Cancer J. Clin.
(2012)
Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients
J. Clin. Oncol.
Mechanisms and function of substrate recruitment by F-box proteins
Nat. Rev. Mol. Cell Biol.
SCF ubiquitin ligase-targeted therapies
Nat. Rev. Drug Discov.
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase
Science
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
EMBO J.
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Nature
FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration
Tumour Biol.
FBXL5 inhibits metastasis of gastric cancer through suppressing Snail1
Cell. Physiol. Biochem.
FBXL5 attenuates RhoGDI2-induced cisplatin resistance in gastric cancer cells
Eur. Rev. Med. Pharmacol. Sci.
Cited by (29)
Selenoprotein S regulates tumorigenesis of clear cell renal cell carcinoma through AKT/ GSK3β/NF-κB signaling pathway
2022, GeneCitation Excerpt :Phosphatidylinositol-3-kinase (PI3K)/protein kinase B(Akt)/the mammalian target of Rapamycin (mTOR), PI3K/Akt/mTOR is an essential pathway for cell growth, proliferation, apoptosis, and angiogenesis. PI3K/Akt/mTOR has been found to be highly expressed in a variety of tumors, and disorders of PI3K/Akt/mTOR pathway can result in multi-system diseases especially tumors (Lin et al., 2018; Cao et al., 2018; Wang et al., 2018; Yao et al., 2018). In recent years, studies of PI3K/Akt/mTOR pathway in kidney-related tumors have gradually become a hit since researchers verified that drug resistance and distant metastases were closely associated with mTOR.
In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma
2021, Pharmacological ResearchCitation Excerpt :The reduction of HEYL eliminated the trend of cell proliferation, migration, and progression in gastric cancer patients [47]. FBXL5 is an E3 ubiquitin ligase, which is related closely to the progression of gastric cancer [48,49], cervical cancer [50], and colon cancer [51]. Through drug analysis, we found that FBXL5 is correlated positively with austocystin and bafilomycin, which have been shown to play important roles in anti-tumor, immune therapy, and autophagy [52–54].
MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway
2020, Cellular SignallingCitation Excerpt :Taken together, UPF1 targeted by CAFs-derived exosomal miR-210 could be responsible for exosomal miR-210-mediated cell migration and invasion in lung cancer. Over-activation of PI3K/AKT signaling occurs in a variety of malignancies and accelerates cell growth [37]. In this study, we unfolded that UPF1 is an inhibitor of the PTEN/PI3K/AKT pathway.